{
  "id": "map_1771",
  "title": "üìö Endocrinolog√≠a\n(32 temas)",
  "specialty": "Endocrinolog√≠a",
  "tag": "üíä Farmacolog√≠a",
  "node_count": 33,
  "root": {
    "text": "üìö Endocrinolog√≠a\n(32 temas)",
    "children": [
      {
        "text": "- Medicamentos para la obesidad-2024",
        "children": []
      },
      {
        "text": "Adultos mayores y diabetes-2024",
        "children": []
      },
      {
        "text": "Amiodarona y tiroides-2024-1",
        "children": []
      },
      {
        "text": "Annals of Internal Medicine In the Clinic Type 2 Diabetes-2024-1",
        "children": []
      },
      {
        "text": "Arteaga | CaÃÅncer diferenciado de tiroides-2024-1",
        "children": []
      },
      {
        "text": "Arteaga | INSUFICIENCIA SUPRARRENAL (ISR)-2024-1",
        "children": []
      },
      {
        "text": "Arteaga | Incidentaloma Suprarrenal-2024-1",
        "children": []
      },
      {
        "text": "Arteaga | Manejo endocrinoloÃÅgico postcirugiÃÅa hipofisiaria.-2024-1",
        "children": []
      },
      {
        "text": "Arteaga. INSUFICIENCIA SUPRARRENAL (ISR)-2024-1",
        "children": []
      },
      {
        "text": "Diabetes en pacientes mayores-2023-1",
        "children": []
      },
      {
        "text": "Diabetes insiÃÅpida-2024-1",
        "children": []
      },
      {
        "text": "Diagnostico y ClasificacioÃÅn de Diabetes-2024-1",
        "children": []
      },
      {
        "text": "Endocrino Hipertiroidismo-2024-1",
        "children": []
      },
      {
        "text": "Endocrino Hipoandrogenismo-2016",
        "children": []
      },
      {
        "text": "Endocrino Hipotiroidismo-2024-1",
        "children": []
      },
      {
        "text": "Endocrino Insuficiencia suprarrenal-2024",
        "children": []
      },
      {
        "text": "Endocrino Sd Cushing-2024",
        "children": []
      },
      {
        "text": "Endocrino-Reumato Osteoporosis-2017",
        "children": []
      },
      {
        "text": "Endocrino. Hiperaldosteronismo primario-2023",
        "children": []
      },
      {
        "text": "Endocrino. Hiperandrogenismo y SOP-2015",
        "children": []
      },
      {
        "text": "FP III. Complicaciones croÃÅnicas de la diabetes-2024-1",
        "children": []
      },
      {
        "text": "FP III. Hipoglicemia en diabeÃÅtico-2024-1",
        "children": []
      },
      {
        "text": "Far Tratamiento de Diabetes Mellitus Tipo 2-2024-1",
        "children": []
      },
      {
        "text": "FisiologiÃÅa tiroides-2024-1",
        "children": []
      },
      {
        "text": "MINSAL. CAÃÅNCER MEDULAR DE TIROIDES (CMT)-2024-1",
        "children": []
      },
      {
        "text": "Mejorando la AtencioÃÅn y Promoviendo la Salud en Poblaciones con Diabetes-2024-1",
        "children": []
      },
      {
        "text": "PATOLOGIÃÅA SUPRARRENAL-2024-1",
        "children": []
      },
      {
        "text": "PaÃÅncreas endocrino-2024-1",
        "children": []
      },
      {
        "text": "Subtipos de diabetes tipo 2-2024-1",
        "children": []
      },
      {
        "text": "TecnologiÃÅas de monitoreo y tratamiento en diabetes-2024-1",
        "children": []
      },
      {
        "text": "Tiroides-2024-1",
        "children": []
      },
      {
        "text": "Trastornos de la corteza suprarrenal-2023",
        "children": []
      }
    ]
  },
  "related_maps": [
    {
      "id": "map_1673",
      "title": "DAPA-CKD (2020)\\NDapagliflozin And Prevention\\Nof Adverse outcomes in CKD\\N\\N‚≠ê iSGLT2 protege ri√±√≥n\\NINCLUSO SIN DIABETES\\N(Extiende beneficio a ERC no-DM)"
    },
    {
      "id": "map_1674",
      "title": "CREDENCE (2019)\\NCanagliflozin and Renal Events in Diabetes\\N\\nCanagliflozina reduce progresion ERC\\ny eventos CV en DM2 con nefropatia\\nNNTH 22 para outcome renal"
    },
    {
      "id": "map_1677",
      "title": "DAPA-HF (2019)\\NDapagliflozin in Heart Failure\\N\\nDapagliflozina reduce muerte CV y hospitalizacion IC\\nen IC-FEr CON y SIN diabetes\\NNNTH 21"
    },
    {
      "id": "map_1710",
      "title": "SELECT (2023)\\NSemaglutide Effects on\\NCardiovascular Outcomes\\Nin Obesity without Diabetes\\N\\n‚≠ê Semaglutida reduce 20%\\Neventos CV en obesidad SIN DM"
    },
    {
      "id": "map_1021",
      "title": "OSTEOPOROSIS POSMENOP√ÅUSICA"
    }
  ],
  "source_file": "Temario_Endocrinolog√≠a.smmx",
  "created": "2026-02-07T15:42:55.314218"
}